Invention Grant
- Patent Title: Ready to use liquid formulation
-
Application No.: US17147953Application Date: 2021-01-13
-
Publication No.: US11642308B2Publication Date: 2023-05-09
- Inventor: Travis A. Leeah , Jianping Chen , Lijie Zhao
- Applicant: QuVa Pharma, Inc.
- Applicant Address: US TX Sugar Land
- Assignee: QUVA PHARMA, INC.
- Current Assignee: QUVA PHARMA, INC.
- Current Assignee Address: US TX Sugar Land
- Agency: Merchant & Gould P.C.
- Agent Daniel R. Evans
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K31/167 ; A61K31/137 ; A61K47/02 ; A61K47/18 ; A61K47/20 ; A61K47/12
Abstract:
Disclosed herein is a ready-to-use liquid, injectable formulation comprising lidocaine and epinephrine. Also disclosed herein is a process for preparing a ready-to-use liquid formulation comprising lidocaine and epinephrine, as well as methods for using the ready-to-use liquid formulation.
Public/Granted literature
- US20210251888A1 READY TO USE LIQUID FORMULATION Public/Granted day:2021-08-19
Information query
